Welcome to our dedicated page for Functional Brands news (Ticker: MEHA), a resource for investors and traders seeking the latest updates and insights on Functional Brands stock.
Functional Brands, Inc. (NASDAQ: MEHA) is a health and wellness company whose news flow centers on its science-based consumer brands, capital markets activity and strategic partnerships. The company regularly issues updates from Lake Oswego, Oregon, highlighting developments across its portfolio, which includes Kirkman®, P2i by Kirkman®, Hemptown Naturals and Healthy Assist by Kirkman.
Investors following MEHA news can expect announcements on product launches and enhancements, such as the Kirkman Skin, Beauty & Anti-Aging Bundle featuring reduced glutathione, zinc cream, biotin and grapefruit seed extract. The company also publishes detailed updates on its P2i by Kirkman prenatal supplement, including alignment with the International Federation of Gynecology and Obstetrics (FIGO) transparency standards and compliance with California’s SB 646 QR-code disclosure requirements for heavy metal testing.
Functional Brands’ news feed also covers financial and regulatory milestones. Examples include quarterly financial results, details of its direct listing on the Nasdaq Capital Market under the symbol MEHA and related SEC disclosures. Strategic communications, such as shareholder letters, outline the company’s mission of "Making Everyone Healthy Again" and describe priorities for growing the Kirkman brand, expanding prenatal offerings and developing direct-to-consumer platforms.
In addition, MEHA news items feature partnership announcements, including a commercial collaboration with Market Performance Group to expand Kirkman’s reach across eCommerce, retail and digital channels, as well as participation in investor conferences. For readers and market participants, the MEHA news page serves as a centralized view of product, financial, partnership and corporate updates directly sourced from the company’s public communications.
Functional Brands (NASDAQ: MEHA) is in advanced talks with multiple strategic financial partners to fund commercialization of BullionFX | Alchemy’s blockchain-based BFX Assets, a gold-backed tokenization platform.
MEHA signed a $142.9 million share-based asset acquisition agreement for BullionFX, and expects key Alchemy staff and advisors to join at no additional cost.
Functional Brands (NASDAQ: MEHA) reported major balance sheet progress while advancing its planned BullionFX | Alchemy asset acquisition. Current liabilities fell nearly 51% in Q1 2026 to about $2.84 million, helped by retiring roughly $3.3 million of derivative liabilities.
Q1 2026 gross profit rose to $961,133 from $866,764, marking the strongest first-quarter gross profit on record. The company outlines a future two-engine model, combining its established wellness operations with the emerging Alchemy blockchain-based, gold-backed digital asset platform, and has initiated Nasdaq procedures for a reverse stock split.
Functional Brands (NASDAQ: MEHA) announced that shareholders approved a reverse stock split, clearing a key condition to close the planned $142.9 million all-stock acquisition of BullionFX | Alchemy.
The company now focuses on completing the transaction, with all remaining closing conditions progressing and further updates expected in coming weeks.
Functional Brands (NASDAQ: MEHA) adjourned its Special Meeting of Stockholders originally set for May 28, 2026. The meeting will reconvene virtually on June 1, 2026 at 10:00 a.m. Eastern Time. The meeting proposals and the April 16, 2026 record date remain unchanged.
Functional Brands (NASDAQ: MEHA) signed a definitive agreement to acquire the Alchemy gold-backed blockchain settlement and DeFi platform from BullionFX in an all-stock asset deal valued at $142.9 million. Boards of both companies approved the transaction, which follows a binding LOI dated May 11, 2026.
The Alchemy ecosystem targets retail, institutional, and blockchain markets, aiming to deliver above-market yield on USD and physical gold positions. Transaction closing remains subject to due diligence, regulatory approvals, and a valuation, with management targeting platform activation around Q3 2026.
Functional Brands (NASDAQ: MEHA) reported first quarter 2026 results for the period ended March 31, 2026.
Revenue was $1.65 million, up 3.5% year-over-year, with gross profit of $0.96 million and gross margin of 58.4%. Operating loss widened to $0.68 million and net loss reached $7.0 million, mainly due to a $6.3 million non-cash charge on equity exchange. The company highlighted direct-to-consumer demand, expansion of Kirkman distribution, traction for Tru2u.health, broader P2i Prenatal placement, a strategic AI partnership, a binding LOI to acquire intellectual property and blockchain-based assets, and completion of a capital structure simplification.
Functional Brands (NASDAQ: MEHA) entered a Conversion Price Reduction and Waiver Agreement with all holders of its Series C Convertible Preferred Stock.
The Series C conversion price during the Fixed Conversion Period is now $0.1636 per common share, replacing prior tiered pricing and waiving below-price conversion limits at this level.
Functional Brands (NASDAQ: MEHA) signed a binding Letter of Intent to acquire the assets of BullionFX | Alchemy in an all-stock deal valued at approximately $142.9 million.
The BullionFX Assets include a blockchain-based, gold-backed DeFi ecosystem designed to link audited physical gold with digital financial applications for retail and institutional users.
Functional Brands (NASDAQ: MEHA) launched GLP-Squared Injection, a dual-peptide formulation combining Semaglutide and Tirzepatide, available exclusively through its Tru2u.health digital platform effective May 6, 2026. The therapy is clinician-prescribed, requires telehealth consultation and lab screening, and is fulfilled via the Tru2u.health ecosystem.
The company positions GLP-Squared as a precision, clinician‑supervised option aiming to deliver combined appetite regulation, glycemic control, and adipose reduction; access is limited to qualifying Tru2u.health members after provider approval.
Functional Brands (NASDAQ: MEHA) expanded its digital health platform Tru2u.health on April 29, 2026 by adding clinically supervised NAD+ therapy.
The platform now combines NAD+ with peptide protocols, GLP-1 weight management, board-certified telehealth, and clean supplements, and is onboarding patients nationwide subject to state telehealth rules.